FDA mustn’t interfere with dying patients’ right to experimental treatments

By David Barnes

Published June 22, 2018 4:00am ET

FDA mustn’t interfere with dying patients’ right to experimental treatments — More than 1 million Americans die each year from a terminal illness. For those patients who are still fighting, recent passage of the federal Right to Try Act will expand access to potentially life-saving treatment before it’s too late. But this will only happen if the Food and Drug Administration faithfully applies the law and […]

More than 1 million Americans die each year from a terminal illness. For those patients who are still fighting, recent passage of the federal Right to Try Act will expand access to potentially life-saving treatment before it’s too late. But this will only happen if the Food and Drug Administration faithfully applies the law and doesn’t stand in the way of patients seeking new hope.

The law bears the name of Matthew Bellina, one of the many Americans who stand to benefit.